U.S. Markets closed

Visualant, Inc. (VSUL)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.27+0.04 (+16.88%)
At close: 12:16PM EDT
People also watch
KNKTCRWGLBYETNGSCOYR
Full screen
Previous Close0.23
Open0.25
Bid0.00 x
Ask0.00 x
Day's Range0.25 - 0.27
52 Week Range0.23 - 1.49
Volume9,500
Avg. Volume10,395
Market Cap1.01M
Beta0.79
PE Ratio (TTM)-0.23
EPS (TTM)-1.18
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Visualant, Inc. :VSUL-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017
    Capital Cubelast month

    Visualant, Inc. :VSUL-US: Earnings Analysis: Q2, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Visualant, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Visualant, Inc. – AMETEK, Inc., MKS Instruments, Inc., Cognex Corporation, Mace Security International, Inc., ESCO Technologies Inc. and Schmitt Industries, Inc. (AME-US, MKSI-US, CGNX-US, MACE-US, ESE-US and SMIT-US) that ... Read more (Read more...)

  • Business Wire2 months ago

    Visualant Granted Biological Tissue Patent

    Visualant, Incorporated – an emerging leader in next-generation optical sensor technology – announced today that it has received its 11th U.S. patent. The invention relates to the use of the company’s disruptive ChromaID™ technology for identifying and analyzing biological tissue, and has many potential applications in healthcare, food safety, cosmetics and other medical, industrial and consumer markets....

  • Business Wire2 months ago

    Visualant Appoints Phillip Bosua to Scientific Advisory Board

    Visualant, Inc. – a provider of chromatic-based identification, authentication and diagnostic solutions, with its patented ChromaID™ technology, announced today that it has appointed Phillip Bosua to its Scientific Advisory Board.